Medicine and Dentistry
Head and Neck Cancer
100%
Head and Neck Squamous Cell Carcinoma
80%
Personalized Medicine
80%
Cancer Staging
80%
Cohort Analysis
80%
Targeted Therapy
80%
Nivolumab
80%
Proton Therapy
80%
Acute Toxicity
80%
Neoplasm
60%
Malignant Neoplasm
60%
Clinical Trial
40%
Immunotherapy
40%
Overall Survival
40%
Progression Free Survival
40%
Mucositis
40%
Photon Therapy
40%
Symptomatic Treatment
20%
Lung Cancer
20%
Biological Marker
20%
Molecular Profiling
20%
Prostate Cancer
20%
Tumor Biopsy
20%
Programmed Death-Ligand 1
20%
Glucocorticoid
20%
Cancer Chemotherapy
20%
Opiate
20%
Patient Selection
20%
Randomized Controlled Trial
20%
Carboplatin
20%
Skin Manifestation
20%
P16
20%
Xerostomia
20%
Dermatitis
20%
Oropharyngeal Cancer
20%
Selection Bias
20%
Plummer-Vinson Syndrome
20%
Patient Compliance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
100%
Nivolumab
80%
Head and Neck Squamous Cell Carcinoma
80%
Cohort Study
80%
Acute Toxicity
80%
Mucosa Inflammation
80%
Progression Free Survival
40%
Overall Survival
40%
Immunotherapy
40%
Xerostomia
40%
Chemotherapy
40%
Skin Manifestation
40%
Oropharynx Cancer
40%
Randomized Controlled Trial
40%
Opiate
40%
Carboplatin
40%
Dermatitis
40%
Neoplasm
40%
Dysphagia
40%
Phase IV
20%
Comorbidity
20%
Glucocorticoid
20%
Nursing and Health Professions
Cohort Analysis
80%
Immunotherapy
40%
Overall Survival
40%
Progression Free Survival
40%
World Health Organization
20%
Palliative Therapy
20%
Cancer Center
20%
Comorbidity
20%
Head and Neck Cancer
20%
Glucocorticoid
20%